BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9819101)

  • 1. Atherothrombogenicity of lipoprotein(a): the debate.
    Scanu AM
    Am J Cardiol; 1998 Nov; 82(9A):26Q-33Q. PubMed ID: 9819101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Learning about the structure and biology of human lipoprotein [a] through dissection by enzymes of the elastase family: facts and speculations.
    Scanu AM; Edelstein C
    J Lipid Res; 1997 Nov; 38(11):2193-206. PubMed ID: 9392417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipoprotein(a): a link between thrombosis and atherosclerosis?].
    Hansen PR
    Ugeskr Laeger; 1993 May; 155(20):1527-30. PubMed ID: 8316983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a): its inheritance and molecular basis of its atherothrombotic role.
    Scanu AM
    Mol Cell Biochem; 1992 Aug; 113(2):127-31. PubMed ID: 1387699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) and atherosclerosis.
    Scanu AM; Lawn RM; Berg K
    Ann Intern Med; 1991 Aug; 115(3):209-18. PubMed ID: 1829339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mutations in human apolipoprotein(a) kringle 4-37 from the study of the DNA of peripheral blood lymphocytes: relevance to the role of lipoprotein(a) in atherothrombosis.
    Scanu AM
    Am J Cardiol; 1995 Feb; 75(6):58B-61B. PubMed ID: 7863976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pharmacological effects of certain compounds on lipoprotein(a)].
    Monte G; Mezdour H
    Recenti Prog Med; 1993 Dec; 84(12):855-63. PubMed ID: 8108601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
    Boffa MB; Marcovina SM; Koschinsky ML
    Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis.
    Caplice NM; Panetta C; Peterson TE; Kleppe LS; Mueske CS; Kostner GM; Broze GJ; Simari RD
    Blood; 2001 Nov; 98(10):2980-7. PubMed ID: 11698280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin: contribution to selective retention of lipoprotein(a) in atherosclerotic lesions.
    D'Angelo A; Geroldi D; Hancock MA; Valtulina V; Cornaglia AI; Spencer CA; Emanuele E; Calligaro A; Koschinsky ML; Speziale P; Visai L
    Biochim Biophys Acta; 2005 Feb; 1687(1-3):1-10. PubMed ID: 15708348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and metabolic differences between elastase-generated fragments of human lipoprotein[a] and apolipoprotein[a].
    Edelstein C; Italia JA; Klezovitch O; Scanu AM
    J Lipid Res; 1996 Aug; 37(8):1786-801. PubMed ID: 8864963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lipoprotein(a) and LDL on plasminogen binding to extracellular matrix and on matrix-dependent plasminogen activation by tissue plasminogen activator.
    Pekelharing HL; Kleinveld HA; Duif PF; Bouma BN; van Rijn HJ
    Thromb Haemost; 1996 Mar; 75(3):497-502. PubMed ID: 8701415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein lipase greatly enhances the retention of lipoprotein(a) to endothelial cell-matrix.
    Auerbach BJ; Cain W; Ansong M; Newton RS; Saxena U; Bisgaier CL
    Atherosclerosis; 1999 Jan; 142(1):89-96. PubMed ID: 9920509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein Lp(a) and CETP (cholesterol ester transfer protein): contribution of transgenic mice].
    Chapman J; Guérin M
    Bull Acad Natl Med; 1994 Mar; 178(3):427-34; discussion 434-6. PubMed ID: 8076182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) catabolism: a case of multiple receptors.
    McCormick SPA; Schneider WJ
    Pathology; 2019 Feb; 51(2):155-164. PubMed ID: 30595508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel insights into Lp(a) physiology and pathogenicity: more questions than answers?
    Koschinsky ML
    Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):267-78. PubMed ID: 17378772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of lipoprotein(a) in atherogenesis and thrombosis.
    Hajjar KA; Nachman RL
    Annu Rev Med; 1996; 47():423-42. PubMed ID: 8712793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).
    Dieplinger H; Kronenberg F
    Wien Klin Wochenschr; 1999 Jan; 111(1):5-20. PubMed ID: 10067265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of lipoprotein[a] in atherosclerosis.
    Morrisett JD
    Curr Atheroscler Rep; 2000 May; 2(3):243-50. PubMed ID: 11122750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) as a risk factor for coronary artery disease.
    Marcovina SM; Koschinsky ML
    Am J Cardiol; 1998 Dec; 82(12A):57U-66U; discussion 86U. PubMed ID: 9915664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.